Monocytes exposed to plasma from patients with Alzheimer’s disease undergo metabolic reprogramming

Publication date: Available online 12 January 2019Source: Neuroscience ResearchAuthor(s): Hannah Wolfe, Virginia Mela Rivas, Aedin M. Minogue, Anne-Marie Miller, Chris McGuigan, Laura Williams, Deirdre Lohan, Brian A. Lawlor, Marina A. LynchAbstractThe search for a blood-based biomarker that identifies Alzheimer’s disease (AD) and can replace current invasive and expensive diagnostic tests, continues. The most extensively-examined peripheral marker is β-amyloid (Aβ) but the results are inconsistent across studies and do not reflect the changes that take place in the brain. Several studies have assessed possible proteomic signatures but with inconsistent findings, although increases in circulating inflammatory molecules are generally observed. Here, rather than focus on identifying changes in the circulation, we evaluated the effect of plasma from patients with mild cognitive impairment (MCI) and AD on the human monocyte-like cell line, THP-1 cells, and plasma from an AD mouse model on a mouse monocyte-macrophage cell line, J774.2 cells. Plasma from AD patients and the AD mouse model increased inflammatory molecules in the cells and these changes were accompanied by an increase in glycolysis. Interestingly, plasma from MCI patients exerted no significant effect on THP-1 cells. The possibility therefore exists that evaluating the effect of plasma on IL-8 and TNFα mRNA in THP-1 cells combined with analysis of glycolysis in these cells, may be the basis of an indicator that ...
Source: Neuroscience Research - Category: Neuroscience Source Type: research